Combined mexiletine and flecainide for severe long QT syndrome type 3.

Shimizu, Toshiyuki; Kawai, Shun; Kawada, Aiko; Wakamiya, Takuya; Nakano, Yusuke; Watanabe, Shigeo; Iwamoto, Mari

Shimizu, Toshiyuki; Kawai, Shun; Kawada, Aiko; Wakamiya, Takuya; Nakano, Yusuke; Watanabe, Shigeo; Iwamoto, Mari.

Afiliação

Shimizu T; Department of Pediatric Cardiology, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
Kawai S; Department of Pediatric Cardiology, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
Kawada A; Department of Pediatric Cardiology, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
Wakamiya T; Department of Pediatric Cardiology, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
Nakano Y; Department of Pediatric Cardiology, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
Watanabe S; Department of Pediatric Cardiology, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
Iwamoto M; Department of Pediatrics, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Kanagawa, Japan.

Pediatr Int ; 65(1): e15517, 2023 01.

Article em En | MEDLINE | ID: mdl-36847291

Assuntos

Síndrome do QT Longo; Mexiletina; Humanos; Mexiletina/uso terapêutico; Flecainida/uso terapêutico; Doença do Sistema de Condução Cardíaco; Síndrome do QT Longo/diagnóstico; Síndrome do QT Longo/tratamento farmacológico; Antiarrítmicos/uso terapêutico; Eletrocardiografia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do QT Longo / Mexiletina Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google